Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL121529 | 0.89 | CHRM2 (0.70) | CHRM2ALDH1A1PKMGAADPP7 | |
| Hydrochloric Acid SCHEMBL9479560 | 0.86 | CHRM2 (0.68) | CHRM2ALDH1A1PKMGAADPP7 | |
| Hydrochloric Acid SCHEMBL2147064 | 0.86 | CHRM2 (0.68) | CHRM2ALDH1A1PKMGAADPP7 | |
| SCHEMBL6050035 | 0.85 | CHRM2 (0.49) | CHRM2ALDH1A1PKMGAADPP7 | |
| SCHEMBL2938432 | 0.84 | CHRM2 (0.78) | CHRM2ALDH1A1PKMGAAKDM4E | |
| 1,4-Dimethoxybenzene SCHEMBL10989906 | 0.84 | CA1 (0.61) | CHRM2ALDH1A1GAAKDM4ERAB9A | |
| SCHEMBL9180552 | 0.83 | LMNA (0.52) | CHRM2ALDH1A1KDM4ESMN1; SMN2MEN1 | |
| SCHEMBL4030406 | 0.83 | CHRM2 (0.70) | CHRM2ALDH1A1PKMGAAKDM4E | |
| SCHEMBL4919379 | 0.83 | CHRM2 (0.81) | CHRM2ALDH1A1PKMGAAKDM4E | |
| SCHEMBL22305119 | 0.83 | CHRM2 (0.63) | CHRM2ALDH1A1PKMGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0806948-B1 | TREATING URINARY INCONTINENCE USING (S)-OXYBUTYNIN AND (S)-DESETHYLOXYBUTYNIN | SEPRACOR INC (US) | 2000-09-13 | — | — | EP | claimed |
| CN-1179714-A | Treatment of urinary incontinence with (S) -oxybutynin and (S) -desethyloxybutynin | SEPRACOR INC (US) | 1998-04-22 | — | — | CN | claimed |
| EP-0806948-A1 | TREATING URINARY INCONTINENCE USING (S)-OXYBUTYNIN AND (S)-DESETHYLOXYBUTYNIN | SEPRACOR, INC. (US) | 1997-11-19 | — | — | EP | claimed |
| US-5677346-A | Treating urinary incontinence using (S)-desethyloxybutynin | SEPRACOR, INC. (US) | 1997-10-14 | — | — | US | claimed |
| WO-1996023492-A1 | TREATING URINARY INCONTINENCE USING (S)-OXYBUTYNIN AND (S)-DESETHYLOXYBUTYNIN | SEPRACOR, INC. (US) | 1996-08-08 | — | — | WO | claimed |
| EP-0140886-A4 | FILM BADGE FOR DETERMINING CARBONYL COMPOUNDS. | LITTLE INC A (US) | 1985-09-02 | — | — | EP | claimed |
| EP-0140886-A1 | FILM BADGE FOR DETERMINING CARBONYL COMPOUNDS. | LITTLE INC A (US) | 1985-05-15 | — | — | EP | claimed |
| WO-1984004165-A1 | FILM BADGE FOR DETERMINING CARBONYL COMPOUNDS | LITTLE INC A (US) | 1984-10-25 | — | — | WO | claimed |
| EP-4727944-A1 | [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT | Perha Pharmaceuticals (FR) | 2026-04-22 | — | — | EP | disclosed |
| US-12577208-B2 | TEAD inhibitors and uses thereof | EHE Foundation (US) | 2026-03-17 | — | — | US | disclosed |
| US-20260008780-A1 | SUBSTITUTED 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE DERIVATIVES AND RELATED USES | NODTHERA LTD (GB) | 2026-01-08 | — | — | US | disclosed |
| US-20250228854-A1 | HETEROCYCLIC SUBSTITUTED PYRIMIDOPYRAN COMPOUNDS AND THEIR APPLICATIONS | D3 BIO (WUXI) CO., LTD (CN) | 2025-07-17 | — | — | US | disclosed |
| CN-119954725-A | TEAD inhibitors and uses thereof | 医肯纳肿瘤学公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-4536350-A1 | SUBSTITUTED 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE DERIVATIVES AND RELATED USES | Nodthera Limited (GB) | 2025-04-16 | — | — | EP | disclosed |
| US-5028256-A | Metolachlor and an acylamide compound, for maize or sorghum | CIBA-GEIGY CORPORATION (US) | 1991-07-02 | — | — | US | disclosed |
| US-4958029-A | Process for the production of isoindoline derivatives, novel intermediates and process for their production | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1990-09-18 | — | — | US | disclosed |
| US-4897109-A | ACYLAMINE DERIVATIVE | CIBA-GEIGY CORPORATION (US) | 1990-01-30 | — | — | US | disclosed |
| EP-0163607-B1 | MEANS FOR THE PROTECTION OF CULTURE PLANTS AGAINST THE PHYTOTOXIC ACTION OF CHLORACETANILIDE HERBICIDES | CIBA-GEIGY AG (CH) | 1989-11-08 | — | — | EP | disclosed |
| EP-0275064-A2 | Process for the production of isoindoline derivatives, novel intermediates and process for their production | Banyu Pharmaceutical Co., Ltd. (JP) | 1988-07-20 | — | — | EP | disclosed |
| EP-0163607-A2 | Means for the protection of culture plants against the phytotoxic action of chloracetanilide herbicides | CIBA-GEIGY AG (CH) | 1985-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228854-A1 | HETEROCYCLIC SUBSTITUTED PYRIMIDOPYRAN COMPOUNDS AND THEIR APPLICATIONS | DPYD, TPMT, TYMP | CHRM2 4711/4885ALDH1A1 147/4885PKM 823/4885 |
| US-20260008780-A1 | SUBSTITUTED 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE DERIVATIVES AND RELATED USES | NOD1, NLRP3, CASP1 | CHRM2 3147/4885ALDH1A1 1139/4885PKM 4808/4885 |
| US-12577208-B2 | TEAD inhibitors and uses thereof | BRCA1, BRAF, MEN1 | CHRM2 1455/4885ALDH1A1 618/4885PKM 2706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.